Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.49 is in line with its 4-year average of 1.36, around the middle of its 4-year range (-80.72–79.43).
As of the fiscal period ended Tuesday, June 30, 2026. 0.94% above its 12-month average of 1.48.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.49.
QUICK RATIO (ACID-TEST)
1.49
QUICK RATIO (ACID-TEST) AVG TTM
1.48
QUICK RATIO (ACID-TEST) AVG 3Y
1.47
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.94%
CURRENT VS 3Y AVG
+1.50%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-50.14%
vs the sector median at left
CDT Equity Inc.
Market Cap
$707297.00
Quick Ratio (Acid-Test)
1.49
TTM Avg
1.48
3Y Avg
1.47
5Y Avg
N/A
Market Cap
$787624.00
Quick Ratio (Acid-Test)
4.64
TTM Avg
5.46
3Y Avg
4.98
5Y Avg
8.82
Market Cap
$570131.00
Quick Ratio (Acid-Test)
0.06
TTM Avg
0.15
3Y Avg
3.02
5Y Avg
6.94
Market Cap
$878396.00
Quick Ratio (Acid-Test)
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$885939.00
Quick Ratio (Acid-Test)
0.46
TTM Avg
3.06
3Y Avg
2.92
5Y Avg
4.33
Market Cap
$888387.00
Quick Ratio (Acid-Test)
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
Market Cap
$1.02M
Quick Ratio (Acid-Test)
7.81
TTM Avg
0.12
3Y Avg
1.01
5Y Avg
1.01
Market Cap
$1.11M
Quick Ratio (Acid-Test)
4.31
TTM Avg
1.47
3Y Avg
1.08
5Y Avg
7.17
Market Cap
$1.14M
Quick Ratio (Acid-Test)
3.75
TTM Avg
3.27
3Y Avg
2.43
5Y Avg
2.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CDT Equity Inc. (CDT) | $707297.00 | 1.49 | 1.48 | 1.47 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | 4.64 | 5.46 | 4.98 | 8.82 |
| HCW Biologics Inc. (HCWB)vs › | $570131.00 | 0.06 | 0.15 | 3.02 | 6.94 |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.46 | 3.06 | 2.92 | 4.33 |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 7.81 | 0.12 | 1.01 | 1.01 |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | 4.31 | 1.47 | 1.08 | 7.17 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | 3.75 | 3.27 | 2.43 | 2.43 |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | 0.46 | 0.56 | 0.51 | 1.01 |
Quick Ratio
1.49
Excludes inventory
Current Ratio
2.14
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.49 |
| 2026-03-29 | 1.40 |
| 2025-12-31 | 1.36 |
| 2025-09-28 | 1.66 |
| 2025-06-29 | 1.45 |
| 2025-03-30 | -80.72 |
| 2024-12-31 | 79.43 |
| 2024-09-29 | 0.12 |
| 2024-06-30 | -43.45 |
| 2024-03-31 | 1.59 |
| 2023-12-31 | 3.18 |
| 2023-09-30 | 2.27 |
| 2023-06-30 | 0.17 |
| 2023-03-31 | 0.16 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 3.63 |
| 2022-06-30 | 9.57 |
| 2022-03-31 | 18.55 |
| 2021-12-31 | 0.54 |
